Boothbay Fund Management »

Immunic shares owned by Boothbay Fund Management

Quarter-by-quarter ownership of Immunic (IMUX) shares owned by Boothbay Fund Management from 13F filings

Historical chart of Boothbay Fund Management investment in Immunic

Tip: Access up to 7 years of quarterly data

All positions including Immunic held by Boothbay Fund Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Immunic by Boothbay Fund Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $201k 13k 15.37

More positions owned by Boothbay Fund Management

State Str Spdr S&p 500 Etf T Tr Unit Put Option (SPY)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
Abivax Sa Sponsored Ads (ABVX)
Revolution Medicines Call Option (RVMD)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Invesco Exch Traded Fd Tr Ii Kbw Bk Etf Call Option (KBWB)
Tesla Motors Call Option (TSLA)
Vaxcyte (PCVX)
Constellation Brands Cl A Call Option (STZ)
Apple Call Option (AAPL)
Advanced Micro Devices Call Option (AMD)
Cornerstone Strategic Value (CLM)
Liquidia Corporation Com New (LQDA)
Amazon Call Option (AMZN)
NVIDIA Corporation Call Option (NVDA)

View all positions for Boothbay Fund Management

Top funds holding Immunic

Standard Life Aberdeen
BVF
Millennium Management
Avidity Partners Management
Braidwell
Laurion Capital Management
Vanguard Capital Management
Jones Hill Capital
Woodline Partners
Soleus Capital Management
Propel Bio Management
Susquehanna International
Nantahala Capital Management
UBS Group
Geode Capital Management

View all funds holding Immunic